Skip to content

Clinical trials

Phase 2 Heart Failure, Systolic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure, Systolic Phase: Phase 2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20161
20174
20181
20191
20211
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Withdrawn3
Terminated2
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Virginia Commonwealth University3
Salubris Biotherapeutics Inc2
University of Aarhus2
Aarhus University Hospital1
Cell to Cure ApS1
Oslo University Hospital1
Queen Mary University of London1
RWTH Aachen University1
University of Cincinnati1
University of Leeds1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure, Systolic14
Heart Failure8
Heart Failure, Diastolic2
Inflammation2
Ketosis2
Atrial Fibrillation1
Atrial Flutter1
Diabetes Mellitus, Type 21
Hypertension, Pulmonary1
Iron Deficiencies1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.